SWK Holdings Corporation Reports Positive Financial Results for Q4 2023

SWK Holdings Corporation, a specialty finance company focused on the life science industry, announced its financial results for the fourth quarter ended December 31, 2023. The company reported a net income of $2.8 million for Q4 2023, consistent with the same period in 2022. For the full year, net income increased to $15.9 million, up from $13.5 million in 2022.

During Q4 2023, SWK closed a $33.0 million public offering of senior notes and repurchased shares totaling a cost of $0.2 million. Post-quarter, an Exclusive Option and Asset Purchase Agreement was signed, potentially adding $6 million through the sale of certain Enteris tangible assets, along with guaranteed annual revenue payments for 2024 and 2025.

The finance receivables segment saw a 16.1% increase in gross finance receivables reaching $288.4 million by year-end, alongside closing four new financing deals amounting to $55.1 million. Despite a slight decrease in adjusted non-GAAP net income for the segment, overall financial health remains strong with a reported book value per share of $22.43.

SWK Holdings continues to strengthen its portfolio, focusing on its core specialty finance segment, reducing Enteris cash burn, and leveraging opportunities to advance its life science financing solutions.